[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Filing overview: This Form 4 reports that Farquhar Scott, a director and >10% owner of Atlassian Corporation (TEAM), executed multiple sales of Class A common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted on 02/12/2025. The filing shows four sale entries totaling 7,665 shares sold in separate batches with weighted-average prices reported as $174.183, $172.3002, $172.9282 and $174.6363 respectively. Shares are held indirectly through Farquhar Investment Partnership No. 2, and beneficial ownership after the transactions is reported as 153,300 shares (indirect). The Form was signed by an attorney-in-fact on 09/03/2025.
Positive
- Trades executed under a Rule 10b5-1 plan, indicating pre-arranged transactions rather than opportunistic insider timing
- Complete disclosure of execution price ranges and weighted-average prices for each tranche, with an undertaking to provide full trade details upon request
- Reporting person identified as director and >10% owner, and indirect holdings clearly disclosed through Farquhar Investment Partnership No. 2
Negative
- Insider disposition of 7,665 shares on a single day (09/02/2025), which reduces the reporting person's indirect holdings
- Material change in share count—beneficial ownership after trades is reported as 153,300 shares (indirect), reflecting a decrease from prior holdings
Insights
TL;DR: Insider sold 7,665 TEAM shares under a pre-set 10b5-1 plan; ownership remains indirect at 153,300 shares.
The transactions were executed pursuant to a Rule 10b5-1 plan, which indicates pre-arranged dispositions rather than opportunistic trading. Total disclosed disposals equal 7,665 Class A shares on 09/02/2025 split across four tranches with reported weighted-average prices per tranche. The filing clarifies that the shares are held indirectly by Farquhar Investment Partnership No. 2 and that the filer is both a director and >10% owner, which requires Section 16 reporting. The Form is routine for insiders who trade under an approved plan.
TL;DR: Use of a documented 10b5-1 plan reduces governance concerns; reporting is compliant and timely.
The filing states the trades were effected under a 10b5-1 plan adopted 02/12/2025, and includes execution price ranges and weighted-average prices for each tranche, plus an undertaking to provide full execution details on request. The presence of an attorney-in-fact signature and clear identification of indirect ownership demonstrate adherence to Form 4 protocols. No derivatives or other compensatory changes are reported.